On ECHEMI
Home > Drugs > Hainan General Alliance Pharmaceutical Co., Ltd.
Hainan General Alliance Pharmaceutical Co., Ltd.
  • Founded in:

    2001-08-30
  • Country:

    China China
  • Address:

    Yonggui Industrial Zone, Xiuying, Haikou, Hainan
  • Tax NO.:

    91460000730054588X
  • Registered Funds:

    180 million yuan
  • Website:

  • Email:

Related Drugs
Ganciclovir for injection
Main ingredient: Ganciclovir Chemical name: 9-(1,3-dihydroxy-2-propyloxymethyl)-guanine Molecular formula: C9H12N5O4 Molecular weight: 255.23.
Name Description Content CAS NO. Registered Holders
Ganciclovir

Nucleoside antiviral drugs. After entering the cell, this product is rapidly phosphorylated to a monophosphate compound, and then becomes a triphosphate compound through the action of cellular kinase. Its phosphorylation in cells infected with cytomegalovirus is faster than that in normal cells. Ganciclovir can competitively inhibit DNA polymerase and incorporate into the DNA of viruses and host cells, thereby inhibiting DNA synthesis. This product has a stronger inhibitory effect on viral DNA polymerase than host cell polymerase. In animal experiments, this product has teratogenic, carcinogenic, immunosuppressive effects and reproductive system toxicity.

More

Nucleoside antiviral drugs. After entering the cell, this product is rapidly phosphorylated to a monophosphate compound, and then becomes a triphosphate compound through the action of cellular kinase. Its phosphorylation in cells infected with cytomegalovirus is faster than that in normal cells. Ganciclovir can competitively inhibit DNA polymerase and incorporate into the DNA of viruses and host cells, thereby inhibiting DNA synthesis. This product has a stronger inhibitory effect on viral DNA polymerase than host cell polymerase. In animal experiments, this product has teratogenic, carcinogenic, immunosuppressive effects and reproductive system toxicity.

82410-32-0 36
Ferrous Lactate Capsules
The main ingredient of this product is ferrous lactate.
Name Description Content CAS NO. Registered Holders
Ferrous lactate

Iron is an indispensable element for the body and is an important component of hemoglobin, myoglobin and various tissue enzymes. Iron deficiency can cause iron deficiency anemia or other iron deficiency diseases. Ferrous lactate has a high absorption rate and can be used as an iron supplement.

More

Iron is an indispensable element for the body and is an important component of hemoglobin, myoglobin and various tissue enzymes. Iron deficiency can cause iron deficiency anemia or other iron deficiency diseases. Ferrous lactate has a high absorption rate and can be used as an iron supplement.

5905-52-2 2
Azithromycin Dispersible Tablets
The main ingredient of this product is azithromycin. Its other scientific name is (2R, 3S, 4R, 5R, 8R, 10R, 11R, 12S, 13S, 14R)-13-[(2,6-dideoxy 3-C-methyl-3-O-methyl-a-L-ribopyranosyl)oxy]-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-[[3,4,6-trideoxy-3-(dimethylamino)-b-D-xylopyranosyl]oxy]-1-oxa-6-azacyclopentadecan-15-one.
Name Description Content CAS NO. Registered Holders
Azithromycin

It inhibits bacterial protein synthesis by hindering the bacterial transpeptidation process. It has antibacterial effects on a variety of Gram-positive aerobic bacteria, Gram-negative aerobic bacteria, anaerobic bacteria, sexually transmitted disease microorganisms and other microorganisms. The mechanism of action is the same as that of erythromycin, mainly binding to the 50S subunit of the bacterial ribosome to inhibit RNA-dependent protein synthesis.

More

It inhibits bacterial protein synthesis by hindering the bacterial transpeptidation process. It has antibacterial effects on a variety of Gram-positive aerobic bacteria, Gram-negative aerobic bacteria, anaerobic bacteria, sexually transmitted disease microorganisms and other microorganisms. The mechanism of action is the same as that of erythromycin, mainly binding to the 50S subunit of the bacterial ribosome to inhibit RNA-dependent protein synthesis.

83905-01-5 39
Azithromycin Dispersible Tablets
The main ingredient of this product is azithromycin. Its other scientific name is (2R, 3S, 4R, 5R, 8R, 10R, 11R, 12S, 13S, 14R)-13-[(2,6-dideoxy-3-C-methyl-3-O-methyl-a-L-ribopyranosyl)oxy]-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-[[3,4,6-trideoxy-3-(dimethylamino)-b-D-xylopyranosyl]oxy]-1-oxa-6-azacyclopentadecan-15-one.
Name Description Content CAS NO. Registered Holders
Azithromycin

It inhibits bacterial protein synthesis by hindering the bacterial transpeptidation process. It has antibacterial effects on a variety of Gram-positive aerobic bacteria, Gram-negative aerobic bacteria, anaerobic bacteria, sexually transmitted disease microorganisms and other microorganisms. The mechanism of action is the same as that of erythromycin, mainly binding to the 50S subunit of the bacterial ribosome to inhibit RNA-dependent protein synthesis.

More

It inhibits bacterial protein synthesis by hindering the bacterial transpeptidation process. It has antibacterial effects on a variety of Gram-positive aerobic bacteria, Gram-negative aerobic bacteria, anaerobic bacteria, sexually transmitted disease microorganisms and other microorganisms. The mechanism of action is the same as that of erythromycin, mainly binding to the 50S subunit of the bacterial ribosome to inhibit RNA-dependent protein synthesis.

83905-01-5 39
Fluorouracil Tablets
The main ingredient of this product is: fluorouracil.
Name Description Content CAS NO. Registered Holders
5-Fluorouracil

It is first converted into 5-fluoro-2-deoxyuridine nucleotide in the body, which inhibits thymine nucleotide synthetase, blocking the conversion of deoxyuridine nucleotide into deoxythymine nucleotide, thereby inhibiting DNA biosynthesis. In addition, it can also be incorporated into RNA, inhibiting RNA synthesis by preventing uracil and orotic acid from incorporating into RNA. This product is a cell cycle-specific drug that mainly inhibits S-phase tumor cells.

More

It is first converted into 5-fluoro-2-deoxyuridine nucleotide in the body, which inhibits thymine nucleotide synthetase, blocking the conversion of deoxyuridine nucleotide into deoxythymine nucleotide, thereby inhibiting DNA biosynthesis. In addition, it can also be incorporated into RNA, inhibiting RNA synthesis by preventing uracil and orotic acid from incorporating into RNA. This product is a cell cycle-specific drug that mainly inhibits S-phase tumor cells.

51-21-8 21
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.